What is Toprol-XL?
Toprol-XL is the extended-release brand of metoprolol succinate, a beta-1-selective beta-blocker approved for high blood pressure in adults and children aged 6 or older, for angina, and for stable heart failure with reduced ejection fraction to reduce cardiovascular death and heart-failure admissions. In MERIT-HF it lowered all-cause mortality by 34% in heart failure. It is a different salt and formulation from immediate-release metoprolol tartrate (Lopressor), although switching uses the same total daily dose.1
Approved products and generic therapeutic-equivalence ratings are listed in the FDA Orange Book.3
Metoprolol blocks mainly beta-1 receptors in the heart; the extended-release tablet produces beta-1 blockade similar to conventional metoprolol tablets taken in divided doses through the day.1
Because blood levels vary between people and do not track the blood-pressure effect closely, the dose is found by individual titration.1
The tablets are white, film-coated and scored, engraved A with a code for each strength, so they can be divided but should not be crushed or chewed.
Metoprolol is broken down by CYP2D6, so inhibitors of that enzyme are likely to raise its levels.
People taking a beta-blocker may not respond to the usual doses of epinephrine used to treat a severe allergic reaction, which matters for anyone with a history of anaphylaxis.
Toprol-XL belongs to the blood pressure medicines; carvedilol and nebivolol are other beta-blockers used in cardiovascular care.
